MARKET

PRGO

PRGO

Perrigo Company
NYSE

Real-time Quotes | Nasdaq Last Sale

41.03
+0.46
+1.13%
Opening 15:05 03/05 EST
OPEN
41.01
PREV CLOSE
40.57
HIGH
41.26
LOW
40.08
VOLUME
558.09K
TURNOVER
--
52 WEEK HIGH
58.83
52 WEEK LOW
38.20
MARKET CAP
5.46B
P/E (TTM)
-33.9540
1D
5D
1M
3M
1Y
5Y
DJ Perrigo Price Target Cut to $45.00/Share From $53.00 by Morgan Stanley
Dow Jones · 6h ago
DJ Perrigo Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 6h ago
Morgan Stanley Maintains Equal-Weight on Perrigo, Lowers Price Target to $45
Morgan Stanley analyst David Risinger maintains Perrigo (NYSE:PRGO) with a Equal-Weight and lowers the price target from $53 to $45.
Benzinga · 6h ago
Global Dry Fluorescence Immunoassay Analyzer Market Insights, Overview, Analysis and Forecast 2020-2029
Mar 05, 2021 (Heraldkeepers) -- The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market...
Heraldkeepers · 8h ago
Global Dental Cotton Rolls Analyzer Market Insights, Overview, Analysis and Forecast 2020-2029
Mar 05, 2021 (Heraldkeepers) -- The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market...
Heraldkeepers · 8h ago
Global Ureteral Access Sheath Market Insights, Overview, Analysis and Forecast 2020-2029
Mar 05, 2021 (Heraldkeepers) -- The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market...
Heraldkeepers · 8h ago
Global Respiratory Dialysis Machines Market Insights, Overview, Analysis and Forecast 2020-2029
Mar 05, 2021 (Heraldkeepers) -- The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market...
Heraldkeepers · 8h ago
Global Vacuum Therapy Devices Market Insights, Overview, Analysis and Forecast 2020-2029
Mar 05, 2021 (Heraldkeepers) -- The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market...
Heraldkeepers · 8h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PRGO. Analyze the recent business situations of Perrigo Company through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 11 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PRGO stock price target is 56.00 with a high estimate of 70.00 and a low estimate of 45.00.
EPS
Institutional Holdings
Institutions: 555
Institutional Holdings: 133.28M
% Owned: 100.14%
Shares Outstanding: 133.10M
TypeInstitutionsShares
Increased
106
5.20M
New
100
-694.42K
Decreased
129
7.84M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+1.25%
Pharmaceuticals & Medical Research
+1.10%
Key Executives
President/Chief Executive Officer/Director
Murray Kessler
Chief Financial Officer/Executive Vice President
Raymond Silcock
Chief Human Resource Officer/Executive Vice President
Robert Willis
Executive Vice President/Chief Information Officer
Thomas Farrington
Executive Vice President/Chief Scientific Officer
James Dillard
Executive Vice President/General Counsel/Secretary
Todd Kingma
Executive Vice President
Svend Andersen
Executive Vice President
Ronald Janish
Executive Vice President
Sharon Kochan
Executive Vice President
Grainne Quinn
Executive Vice President
Rich Sorota
Director
Orlando Ashford
Director
Katherine Doyle
Independent Director
Bradley Alford
Independent Director
Rolf Classon
Independent Director
Adriana Karaboutis
Independent Director
Jeffrey Kindler
Independent Director
Erica Mann
Independent Director
Donal O'Connor
Independent Director
Geoffrey Parker
Independent Director
Theodore Samuels
Declaration Date
Dividend Per Share
Ex-Div Date
02/23/2021
Dividend USD 0.24
03/11/2021
10/22/2020
Dividend USD 0.225
11/25/2020
07/29/2020
Dividend USD 0.225
08/27/2020
05/05/2020
Dividend USD 0.225
05/28/2020
02/18/2020
Dividend USD 0.225
02/27/2020
11/04/2019
Dividend USD 0.21
11/27/2019
07/31/2019
Dividend USD 0.21
08/29/2019
04/26/2019
Dividend USD 0.21
05/30/2019
02/14/2019
Dividend USD 0.19
02/28/2019
10/31/2018
Dividend USD 0.19
11/29/2018
08/01/2018
Dividend USD 0.19
08/30/2018
05/03/2018
Dividend USD 0.19
05/31/2018
02/15/2018
Dividend USD 0.19
03/01/2018
11/02/2017
Dividend USD 0.16
11/30/2017
08/08/2017
Dividend USD 0.16
08/23/2017
05/03/2017
Dividend USD 0.16
05/24/2017
02/21/2017
Dividend USD 0.16
03/01/2017
11/08/2016
Dividend USD 0.145
11/22/2016
08/02/2016
Dividend USD 0.145
08/24/2016
04/26/2016
Dividend USD 0.145
05/25/2016
02/16/2016
Dividend USD 0.145
02/24/2016
11/04/2015
Dividend USD 0.125
11/24/2015
08/12/2015
Dividend USD 0.125
08/26/2015
04/28/2015
Dividend USD 0.125
05/27/2015
01/27/2015
Dividend USD 0.125
02/25/2015
11/03/2014
Dividend USD 0.105
11/25/2014
08/13/2014
Dividend USD 0.105
08/27/2014
04/28/2014
Dividend USD 0.105
05/28/2014
01/29/2014
Dividend USD 0.105
02/26/2014
--
Dividend USD 0.09
11/26/2013
08/14/2013
Dividend USD 0.09
08/28/2013
About PRGO
Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by enabling consumers to proactively prevent or treat conditions that can be self-managed. The Company operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the United States (U.S.), Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with generic consumer-focused businesses in the United Kingdom (U.K.) and Australia. The Prescription Pharmaceuticals segment commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel.

Webull offers kinds of Perrigo Company PLC stock information, including NYSE:PRGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRGO stock methods without spending real money on the virtual paper trading platform.